Paul Walker's Insider Trades & SAST Disclosures
Paul Walker's most recent trade in Franklin Covey Co. was a trade of 3,600 common shares done . Disclosure was reported to the exchange on Nov. 13, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Paul Walker.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Franklin Covey Co. | Paul S. Walker | Director, CEO, Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Nov 2024 | 3,600 | 98,299 (0%) | 0% | 0 | common shares | |
| NeueHealth Inc. | Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Oct 2024 | 185,595 | 556,782 | - | - | Warrant (Right to Buy) | |
| NeueHealth Inc. | Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Oct 2024 | 61,865 | 185,594 | - | - | Warrant (Right to Buy) | |
| NeueHealth Inc. | Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Oct 2024 | 61,865 | 185,594 | - | - | Warrant (Right to Buy) | |
| Allakos Inc | Paul Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 41,000 | 41,000 | - | - | Stock Option (Right to buy) | |
| NeueHealth Inc. | Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Apr 2024 | 371,187 | 371,187 | - | - | Warrant (Right to Buy) | |
| NeueHealth Inc. | Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Apr 2024 | 123,729 | 123,729 | - | - | Warrant (Right to Buy) | |
| NeueHealth Inc. | Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Apr 2024 | 123,729 | 123,729 | - | - | Warrant (Right to Buy) | |
| Bright Health Group Inc | Walker Paul | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Dec 2023 | 175,525 | 1,656,789 | - | - | Warrant (Right to Buy) | |
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Oct 2023 | 100,606 | 1,481,264 | - | - | Warrant (Right to Buy) | |
| Franklin Covey Co. | Paul S. Walker | Director, CEO, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2023 | 36,957 | 93,159 (0%) | 0% | 0 | Common shares | |
| Franklin Covey Co. | Paul S. Walker | Director, CEO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.06 per share. | 06 Oct 2023 | 27,430 | 65,729 (0%) | 0% | 41.1 | 1,126,276 | Common shares |
| Franklin Covey Co. | Paul S. Walker | Director, CEO, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2023 | 13,456 | 56,202 (0%) | 0% | 0 | Common shares | |
| Franklin Covey Co. | Paul S. Walker | Director, CEO, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2023 | 9,895 | 75,624 (0%) | 0% | 0 | Common shares | |
| Franklin Covey Co. | Paul S. Walker | Director, CEO, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2023 | 5,767 | 42,746 (0%) | 0% | 0 | Common shares | |
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Sep 2023 | 552,263 | 1,380,658 | - | - | Warrant (Right to Buy) | |
| Franklin Covey Co. | Paul S. Walker | Director, CEO, Director | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Aug 2023 | 3,300 | 36,979 (0%) | 0% | 0 | Common shares | |
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Aug 2023 | 828,395 | 828,395 | - | - | Warrant (Right to Buy) | |
| Mirum Pharmaceuticals Inc | Paul Walker | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Jun 2023 | 2,000,000 | 2,186,243 (8%) | 8% | 0 | Common Stock | |
| Mirum Pharmaceuticals Inc | Paul Walker | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Jun 2023 | 30,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| Mirum Pharmaceuticals Inc | Paul Walker | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Jun 2023 | 30,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Mirum Pharmaceuticals Inc | Paul Walker | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Jun 2023 | 114 | 114 (0%) | 0% | 0 | Common Stock | |
| Allakos Inc | Paul Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 86,762 | 86,762 | - | - | Stock Option (Right to buy) | |
| Franklin Covey Co. | S. Walker Paul | Director, CEO, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 27,446 | 123,842 (0%) | 0% | 0 | common shares | |
| Franklin Covey Co. | S. Walker Paul | Director, CEO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.85 per share. | 09 Dec 2022 | 21,943 | 101,899 (0%) | 0% | 40.9 | 896,372 | common shares |
| Franklin Covey Co. | S. Paul Walker | Director, CEO, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 12,494 | 96,396 (0%) | 0% | 0 | common shares | |
| Franklin Covey Co. | Walker S. Paul | Director, CEO, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 5,355 | 83,902 (0%) | 0% | 0 | common shares | |
| Franklin Covey Co. | Walker S. Paul | Director, CEO, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 2,923 | 78,547 (0%) | 0% | 0 | common shares | |
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 17 Oct 2022 | 100,000 | 100,000 | - | - | Series B Convertible Perpetual Preferred Stock | |
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 17 Oct 2022 | 37,700 | 37,700 | - | - | Series B Convertible Perpetual Preferred Stock | |
| Franklin Covey Co. | Paul S. Walker | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Oct 2022 | 3,986 | 40,279 (0%) | 0% | 0 | common shares | |
| Franklin Covey Co. | Paul S. Walker | CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.05 per share. | 14 Oct 2022 | 1,318 | 36,293 (0%) | 0% | 47.1 | 62,012 | common shares |
| Allakos Inc | Paul Walker | Director | Purchase of securities on an exchange or from another person at price $ 5.02 per share. | 21 Sep 2022 | 3,386,400 | 3,386,400 (6%) | 6% | 5.0 | 16,999,728 | Common Stock |
| Allakos Inc | Paul Walker | Director | Purchase of securities on an exchange or from another person at price $ 5.02 per share. | 21 Sep 2022 | 597,600 | 2,760,860 (5%) | 1% | 5.0 | 2,999,952 | Common Stock |
| Franklin Covey Co. | Paul S. Walker | CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Aug 2022 | 2,100 | 37,611 (0%) | 0% | 0 | common shares | |
| Franklin Covey Co. | Paul S. Walker | CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Aug 2022 | 1,555 | 39,711 (0%) | 0% | 0 | common shares | |
| Allakos Inc | Paul Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 99,590 | 99,590 | - | - | Stock Option (Right to Buy) | |
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2022 | 125,000 | 125,000 | - | - | Series A Convertible Perpetual Preferred Stock | |
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2022 | 75,000 | 75,000 | - | - | Series A Convertible Perpetual Preferred Stock | |
| Franklin Covey Co. | Paul S. Walker | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 11,646 | 43,270 (0%) | 0% | 0 | common shares | |
| Franklin Covey Co. | Paul S. Walker | CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.99 per share. | 01 Oct 2021 | 6,579 | 36,691 (0%) | 0% | 41.0 | 269,673 | common shares |
| Franklin Covey Co. | Paul S. Walker | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 4,575 | 41,266 (0%) | 0% | 0 | common shares | |
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | 28 Jun 2021 | 38,137,197 | 44,001,915 | - | - | Common Stock | ||
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | 28 Jun 2021 | 14,942,061 | 14,942,061 | - | - | Common Stock | ||
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | 28 Jun 2021 | 12,712,399 | 0 | - | - | Series D Preferred | ||
| Monte Rosa Therapeutics Inc | Paul Walker | Ten Percent Owner | 28 Jun 2021 | 11,500,000 | 0 | - | - | Series B convertible preferred stock | ||
| Monte Rosa Therapeutics Inc | Paul Walker | Ten Percent Owner | 28 Jun 2021 | 9,588,725 | 0 | - | - | Series A-2 convertible preferred stock | ||
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | 28 Jun 2021 | 7,346,568 | 22,288,629 | - | - | Common Stock | ||
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | 28 Jun 2021 | 5,864,718 | 5,864,718 | - | - | Common Stock | ||
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | 28 Jun 2021 | 4,980,687 | 0 | - | - | Series D Preferred | ||
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | 28 Jun 2021 | 3,673,284 | 47,675,199 | - | - | Common Stock | ||
| Monte Rosa Therapeutics Inc | Paul Walker | Ten Percent Owner | 28 Jun 2021 | 3,257,328 | 5,973,296 | - | - | Common Stock | ||
| Monte Rosa Therapeutics Inc | Paul Walker | Ten Percent Owner | 28 Jun 2021 | 2,715,968 | 2,715,968 | - | - | Common Stock | ||
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | 28 Jun 2021 | 2,448,856 | 0 | - | - | Series E Preferred | ||
| Monte Rosa Therapeutics Inc | Paul Walker | Ten Percent Owner | 28 Jun 2021 | 2,361,912 | 0 | - | - | Series C convertible preferred Stock | ||
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | 28 Jun 2021 | 1,954,906 | 0 | - | - | Series C Preferred | ||
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 28 Jun 2021 | 1,694,444 | 23,983,073 | - | 18 | 30,499,992 | Common Stock |
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | 28 Jun 2021 | 1,224,428 | 0 | - | - | Series E Preferred | ||
| Monte Rosa Therapeutics Inc | Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 28 Jun 2021 | 1,050,000 | 7,692,298 | - | 19 | 19,950,000 | Common Stock |
| Monte Rosa Therapeutics Inc | Paul Walker | Ten Percent Owner | 28 Jun 2021 | 669,002 | 6,642,298 | - | - | Common Stock | ||
| Bright Health Group Inc | Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 28 Jun 2021 | 250,000 | 47,925,199 | - | 18 | 4,500,000 | Common Stock |
| Allakos Inc | Paul Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 7,700 | 7,700 | - | - | Stock Option (Right to buy) | |
| Marker Therapeutics Inc | Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 16 Mar 2021 | 5,714,285 | 10,714,285 (23%) | 12% | 1.8 | 9,999,999 | Common Stock |
| Franklin Covey Co. | Paul S. Walker | EVP, Direct Offices Division | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2020 | 18,675 | 36,919 (0%) | 0% | 0 | common shares | |
| Franklin Covey Co. | Paul S. Walker | EVP, Direct Offices Division | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.25 per share. | 02 Oct 2020 | 8,273 | 28,646 (0%) | 0% | 17.2 | 142,709 | common shares |
| Franklin Covey Co. | Paul S. Walker | EVP, Direct Offices Division | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2020 | 6,160 | 34,806 (0%) | 0% | 0 | common shares | |
| TRACON Pharmaceuticals Inc | Paul Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 4,500 | 4,500 | - | - | Director Stock Option (Right to Buy) | |
| Allakos Inc | Paul Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2020 | 7,700 | 7,700 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges